Holen Sie sich die Stockscreener-App
11.93
3.56%
0.41
Handel nachbörslich:
11.95
0.02
+0.17%
Schlusskurs vom Vortag:
$11.52
Offen:
$11.57
24-Stunden-Volumen:
784.10K
Relative Volume:
1.62
Marktkapitalisierung:
$564.47M
Einnahmen:
$502.79M
Nettoeinkommen (Verlust:
$23.71M
KGV:
23.86
EPS:
0.5
Netto-Cashflow:
$6.35M
1W Leistung:
+2.84%
1M Leistung:
+10.98%
6M Leistung:
-31.08%
1J Leistung:
-40.29%
1-Tages-Spanne:
$11.28
$12.21
1-Wochen-Bereich:
$11.28
$12.21
52-Wochen-Spanne:
$10.14
$25.13
Core Laboratories Inc Stock (CLB) Company Profile
Firmenname
Core Laboratories Inc
Sektor
Telefon
713-328-2673
Adresse
6316 WINDFERN ROAD, HOUSTON
Vergleichen Sie CLB mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CLB
Core Laboratories Inc
|
11.93 | 564.47M | 502.79M | 23.71M | 6.35M | 0.50 |
|
SLB
Schlumberger Ltd
|
35.19 | 47.99B | 36.07B | 4.19B | 4.79B | 2.95 |
|
BKR
Baker Hughes Company
|
38.69 | 38.72B | 27.84B | 2.93B | 2.01B | 2.93 |
|
TS
Tenaris S A Adr
|
36.98 | 19.28B | 13.09B | 2.65B | 2.52B | 4.5936 |
|
HAL
Halliburton Co
|
21.20 | 19.08B | 22.56B | 2.10B | 2.34B | 2.39 |
|
FTI
Technipfmc Plc
|
34.63 | 13.82B | 9.27B | 827.80M | 1.24B | 1.90 |
Core Laboratories Inc Stock (CLB) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-03-12 | Hochstufung | Citigroup | Sell → Neutral |
| 2023-06-30 | Herabstufung | Citigroup | Neutral → Sell |
| 2023-04-18 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2023-01-09 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2022-10-07 | Hochstufung | Citigroup | Sell → Neutral |
| 2022-09-26 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2022-04-18 | Herabstufung | Piper Sandler | Neutral → Underweight |
| 2021-10-18 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2021-07-09 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-06-14 | Herabstufung | Citigroup | Neutral → Sell |
| 2020-12-18 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2020-11-11 | Bestätigt | Cowen | Market Perform |
| 2020-10-13 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2020-09-29 | Hochstufung | ABN Amro | Sell → Hold |
| 2020-07-16 | Herabstufung | Scotiabank | Sector Outperform → Sector Perform |
| 2020-04-13 | Hochstufung | Scotiabank | Sector Perform → Sector Outperform |
| 2020-03-09 | Herabstufung | BofA/Merrill | Buy → Underperform |
| 2020-03-09 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2020-01-31 | Bestätigt | Cowen | Market Perform |
| 2020-01-30 | Fortgesetzt | Johnson Rice | Buy |
| 2020-01-14 | Eingeleitet | Bernstein | Mkt Perform |
| 2020-01-02 | Herabstufung | Stifel | Buy → Hold |
| 2019-12-31 | Bestätigt | Cowen | Market Perform |
| 2019-07-10 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2019-02-25 | Hochstufung | Tudor Pickering | Hold → Buy |
| 2018-12-19 | Herabstufung | Credit Suisse | Outperform → Neutral |
| 2018-12-11 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2018-11-16 | Hochstufung | Guggenheim | Neutral → Buy |
| 2018-11-01 | Hochstufung | ABN Amro | Sell → Buy |
| 2018-10-29 | Bestätigt | Cowen | Market Perform |
Alle ansehen
Core Laboratories Inc Aktie (CLB) Neueste Nachrichten
What is Zacks Research’s Forecast for CLB FY2025 Earnings? - Defense World
Core Laboratories (NYSE:CLB) Stock Price Up 4%Here's What Happened - MarketBeat
What is Zacks Research's Forecast for CLB FY2025 Earnings? - MarketBeat
GAMMA Investing LLC Acquires 62,267 Shares of Core Laboratories Inc. (NYSE:CLB) - MarketBeat
Core Laboratories Inc. (NYSE:CLB) Shares Bought by GAMMA Investing LLC - Defense World
Rhumbline Advisers Increases Position in Core Laboratories Inc. (NYSE:CLB) - Defense World
Is There An Opportunity With Core Laboratories Inc.'s (NYSE:CLB) 49% Undervaluation? - simplywall.st
Is There An Opportunity With Core Laboratories Inc.'s (NYSE:CLB) 50% Undervaluation? - Yahoo Finance
Bank of America Corp DE Cuts Stake in Core Laboratories Inc. (NYSE:CLB) - MarketBeat
Millennium Management LLC Grows Stake in Core Laboratories Inc. (NYSE:CLB) - MarketBeat
Core Laboratories Inc. (NYSE:CLB) Shares Sold by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - Defense World
Mackenzie Financial Corp Makes New Investment in Core Laboratories Inc. (NYSE:CLB) - MarketBeat
Core Laboratories Inc (CLB) Stock Price Down 3.44% on Jun 4 - GuruFocus
Bank of America Corp DE Sells 124,816 Shares of Core Laboratories Inc. (NYSE:CLB) - Defense World
Core Laboratories Inc. (NYSE:CLB) Shares Acquired by Millennium Management LLC - Defense World
Two Sigma Investments LP Has $1.46 Million Holdings in Core Laboratories Inc. (NYSE:CLB) - Defense World
Ameriprise Financial Inc. Sells 221,067 Shares of Core Laboratories Inc. (NYSE:CLB) - MarketBeat
Nuveen Asset Management LLC Has $2.25 Million Stake in Core Laboratories Inc. (NYSE:CLB) - Defense World
Squarepoint Ops LLC Buys 53,188 Shares of Core Laboratories Inc. (NYSE:CLB) - MarketBeat
BNP Paribas Financial Markets Purchases New Stake in Core Laboratories Inc. (NYSE:CLB) - Defense World
14,152 Shares in Core Laboratories Inc. (NYSE:CLB) Acquired by ProShare Advisors LLC - Defense World
Ameriprise Financial Inc. Has $2.02 Million Stock Position in Core Laboratories Inc. (NYSE:CLB) - Defense World
Core Laboratories Inc. (NYSE:CLB) Shares Purchased by MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. - Defense World
D. E. Shaw & Co. Inc. Sells 76,098 Shares of Core Laboratories Inc. (NYSE:CLB) - MarketBeat
Deutsche Bank AG Has $802,000 Stock Holdings in Core Laboratories Inc. (NYSE:CLB) - Defense World
Core Laboratories Shareholders Approve Key Proposals - Investing.com
Core Laboratories Shareholders Approve Key Governance Items - TipRanks
Core Laboratories Shareholders Approve Key Proposals By Investing.com - Investing.com UK
Zacks Research Issues Pessimistic Outlook for CLB Earnings - Defense World
Jane Street Group LLC Buys 39,364 Shares of Core Laboratories Inc. (NYSE:CLB) - MarketBeat
Core Laboratories Inc. (NYSE:CLB) Shares Acquired by Northern Trust Corp - MarketBeat
Why Is Core Laboratories (CLB) Down 5.9% Since Last Earnings Report? - Yahoo Finance
Former Core Labs Global Sales Director Brings 20-Year Oil Tech Expertise to Canuc Board - Stock Titan
Raiffeisen Bank International AG Purchases New Stake in Core Laboratories Inc. (NYSE:CLB) - MarketBeat
Zacks Research Brokers Lower Earnings Estimates for CLB - Defense World
Abbott Laboratories' Diagnostics segment revenue from 2020 to 2024, by category - Statista
Northern Trust Corp Has $10 Million Stock Holdings in Core Laboratories Inc. (NYSE:CLB) - Defense World
Zacks Research Cuts Earnings Estimates for Core Laboratories - Defense World
Core Laboratories Down 30% YTD: Should You Hold or Sell the Stock? - MSN
Will Weakness in Core Laboratories Inc.'s (NYSE:CLB) Stock Prove Temporary Given Strong Fundamentals? - Yahoo Finance
Dimensional Fund Advisors LP Has $14.68 Million Stock Position in Core Laboratories Inc. (NYSE:CLB) - MarketBeat
35,017 Shares in Core Laboratories Inc. (NYSE:CLB) Purchased by First Trust Advisors LP - MarketBeat
Core Laboratories (CLB) Stock Price Target Lowered by Citigroup - GuruFocus
Core Laboratories (CLB) Stock Price Target Lowered by Citigroup | CLB Stock News - GuruFocus
Core Laboratories (CLB) Receives Price Target Cut from Citi | CL - GuruFocus
Finanzdaten der Core Laboratories Inc-Aktie (CLB)
Umsatz
Nettogewinn
Free Cashflow
ENV
Core Laboratories Inc-Aktie (CLB) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Tattoli Mark Damian | SVP, Gen Counsel & Secretary |
May 01 '25 |
Option Exercise |
0.00 |
450 |
0 |
16,243 |
| Temeng Kwaku | Director |
Apr 01 '25 |
Option Exercise |
0.00 |
9,317 |
0 |
25,528 |
| Murray Katherine | Director |
Apr 01 '25 |
Option Exercise |
0.00 |
9,317 |
0 |
21,221 |
| Klingensmith Harvey Robert | Director |
Apr 01 '25 |
Option Exercise |
0.00 |
9,317 |
0 |
41,962 |
| Carnes Martha Z. | Director |
Apr 01 '25 |
Option Exercise |
0.00 |
9,317 |
0 |
46,328 |
| ANASTASIO CURT | Director |
Apr 01 '25 |
Option Exercise |
0.00 |
9,317 |
0 |
15,736 |
| Straughen Michael | Director |
Apr 01 '25 |
Option Exercise |
0.00 |
9,317 |
0 |
29,186 |
| Bruno Lawrence | Chairman and CEO |
Dec 31 '24 |
Option Exercise |
0.00 |
69,574 |
0 |
232,777 |
| Hill Christopher Scott | SVP & CFO |
Dec 31 '24 |
Option Exercise |
0.00 |
23,607 |
0 |
95,656 |
| Gresham Gwendolyn | SVP |
Dec 31 '24 |
Option Exercise |
0.00 |
9,604 |
0 |
33,564 |
2.90%
1.17%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):